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Objectives: We investigated the effects of Photodynamic therapy (PDT) using Aluminium disulphonated phthalocyanine 
(A1S2Pc) on experimental intimaI hyperplasia (FCIH). 
Materials and Methods: (a) Pharmacokinetics: Normal rats were injected with AlszPc and carotid arterdj fluorescence 
was measured. (b) Normal artery PDT: Sensitised rats underwent carotid artery laser irradiation (50]/cm ~, 675nm) and 
were assessed after 3 and 14 days and 1-6 months. (c) PDT: Rats underwent standard carotid artery balloon injury 
immediately prior to PDT and arteries were assessed at 2 to 26 weeks, together with laser, A1S2Pc, and untreated 
controls. 
Chief Outcome Measures: (a) Fluorescence intensity in different arterial layers. (b) Medial smooth muscle cell counts per 
high power field (light microscopic). (c) Percentage amount of FCIH (area of intimal hyperplasia) sa ratio of the IEL (area 
enclosed by the internal elastic lamina). 
Results: (a) AIS2Pc fluorescence intensity increased with increasing dosage, with maximal f uorescence in the arterial 
media t 30 min. (b) PDT produced medial cell depletion at 3 days and persisted over 6 months without loss of vessel 
integrity. (c) PDT completely inhibited FCIH at 2 and 4 weeks. This was partial at 6 to 26 weeks (517o f untreated level). 
PDT inhibition of FCIH was significantly greater than in any of the control groups, p < 0.0001. Mann-Whitney Test. 
Conclusion: Adjunctive AISzPc sensitised photodynamic therapy inhibits experimental intimal hyperplasia, by causing 
medial smooth muscle cell depletion. This offers a new approach to the management of angioplasty restenosis n 
patients. 
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Introduction 
There is an increasing tendency to treat suitable 
atheromatous strictures by percutaneous endovas- 
cular procedures such as percutaneous transluminal 
angioplasty (PTA). 1 PTA allows the restoration of 
arterial patency in selected stenoses and occlusions 
without he need for surgical reconstruction a d may 
offer safer and cheaper management of patients with 
arterial disease. The high early success rates reported 
for PTA are, however, limited by the recurrence or 
worsening of symptoms (restenosis) in some 30-50% 
of patients within the first year. 2'3 
Experimental clinical and post mortem studies 
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have shown that one important component of reste- 
nosis is local migration and proliferation of vascular 
smooth muscle cells (SMC) from the media into the 
intima. Here, fibrocellular intimal hyperplasia (FCIH) 
is formed by further cell proliferation and secretion of 
ground substance. 4-7 This process is relatively non- 
specific as it appears in response to differing types of 
injury. 8-1° Complex mechanisms control these SMC 
interactions and many different cytokines have been 
implicated in the process. 1°-12 To date no drugs have 
been clinically effective in preventing or reducing the 
FCIH response to angioplasty. ~'13 Photodynamic ther- 
ap)~ offers an encouraging new approach to this 
difficult problem. 
Photodynamic therapy (PDT) involves the local 
activation of a systemically administered photosensi- 
tiser drug by light of a wavelength which is matched 
to the absorption characteristics of the sensitiser. ~4 
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Activation by an appropriate light dose in the pres- 
ence of tissue oxygen causes photosensitised genera- 
tion of cytotoxic oxidisers such as singlet oxygen, 
which cause cell death. These highly reactive oxidisers 
have a very short diffusion distance, and the area of 
death is localised. PDT is an attractive treatment for 
localised lesions, and recent reports of its effectiveness 
in preventing or reducing experimental FCIH have 
been encouraging. 15-17 We have recently reported the 
early results of FCIH inhibition using aminolaevulinic 
acid (ALA) sensitisation. 18 This endogenous sensitiser 
is less potent han A1S2Pc, has high but transient skin 
photosensitivity, and may not fully penetrate the 
increased epth of human arteries. 
Aluminium disulphonated phthalocyanine (A1S2Pc) 
is a purified exogenous phthalocyanine s nsitiser with 
many advantages over previously used haematopor- 
phyrin derived sensitisers. It has good fluorescence 
properties which enables study of its pharmacoki- 
netics. A potent photosensitiser with excellent absorp- 
tion at 675nm, it induces little skin hypersensitivity n 
ambient light. ~9 
In this study we sought o define the pharmacoki- 
netics and PDT effects of Als2Pc on the medial SMC in 
normal rat carotid arteries, as a preliminary step to its 
administration asan adjunct o balloon injury. Fluores- 
cence is an inherent photoproperty of sensitisers and 
its detection allows quantification of the photoactivity 
of Als2Pc for determining the best time for PDT 
irradiation. The effectiveness of Als2Pc sensitised PDT 
in causing media SMC depletion is assessed and the 
lowest dose of A1S2Pc which effectively produced 
media SMC depletion in normal vessels has been used 
for PDT in balloon injured vessels. PDT treatment is
given at the time of angioplasty injury and its 
effectiveness in preventing FCIH is assessed 2 weeks 
to 6 months after injury. 
Materials and Methods 
Photosensitiser 
A1S2Pc in its purified form was obtained from the 
Department ofChemistry, Imperial College of Science, 
20 Technology and Medicine, London, U.K. The photo- 
sensitiser was made up in 0.1 molar sodium hydroxide 
and phosphate buffered saline and administered 
intravenously by tail vein injection. The concentration 
of A1S2Pc was adjusted to maintain the volume of 
injection between 0.3 and 0.6ml to ensure accurate 
injection. 
Animals 
All studies were performed on mature adult male 
Wistar rats (University College London, U.K.) ranging 
from 300-350g. Injections of A1S2Pc were carried out 
under intramuscular hypnorm (fentanyl and fluani- 
sone) sedation. Photodynamic therapy was performed 
during surgical exposure of the left carotid artery after 
intraperitoneal hypnorm (0.3ml) and diazepam 
(0.3ml) anaesthesia. 
Distribution of AIS2Pc in the normal carotid artery 
Four groups of rats were sensitised with A1S2Pc doses 
of 0.5, 1.0, 2.5 and 5 mg/kg. At intervals ranging from 
5 min to 24 h after sensitisation the rats were killed by 
rising concentration f carbon dioxide and the carotid 
arteries exposed, resected and immediately frozen by 
submersion i  a bath of isopentane (2-methylbutane) 
prechilled in liquid nitrogen. The frozen arteries were 
stored in liquid nitrogen until sectioning. Five milli- 
metre blocks of artery were mounted on OCT medium 
(tissue tek 11 embedding compound, BDH) and three 
10ttm sections taken onto slides using a Cryocut E 
microtome (Reichert-Jung). These were stored in a 
freezer at -20°C. The slides were thawed just prior to 
fluorescence microscopy using an inverted microscope 
with epifluorescence and phase-contrast attach- 
mentsY The fluorescence was excited using an 8 mW 
helium-neon laser (632.8nm) and the beam delivered 
by a liquid light guide. The phthalocyanine fluores- 
cence was detected between 665 and 700nm using a 
combination of band pass (Omega Optical Inc.) and 
long-pass (Schott RG665) filters. The fluorescence 
signal was detected by a highly sensitive cryogenically 
cooled slow scan CCD (charge-coupled device) cam- 
era (Wright instruments, model 1, resolution 400 × 
600 pixels) fitted to the microscope. This signal was 
processed by a personal computer into a falsely 
colour-coded microscopic mage of the section depict- 
ing the counts per pixel in arbitrary units. Quantita- 
tive analysis was performed by measuring the mean 
fluorescence count within the intima, media, and 
adventitia on the fluorescence image. Six readings 
were taken from each layer of artery wall in each 
section and three sections from each of three rats killed 
at each dose/time point studied. Autofluorescence 
was measured from control sections and subtracted 
from the sensitiser fluorescence. Conventional light 
microscopy of the same specimens fixed in formalin 
and stained with haematoxylin and eosin were used 
for comparative light microscop3a 
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Photodynamic therapy of normal arteries 
In all PDT studies the interval between sensitisation 
and irradiation was 30 min, the time of peak arterial 
sensitisation for all doses of A1SzPc. 
(1) Intraluminal versus extraluminal irradiation. Six rats 
were sensitised with the same A1SzPc dose of 5 mg/kg 
for PDT. In three rats PDT was given to the carotid 
artery using the external beam irradiation of a pulsed 
(12 kHz) copper vapour pumped dye laser (Oxford 
lasers) peaked at 675nm with a laser tip power of 
150-200 mW. The laser was adjusted through a 
microlens to deliver a uniform 1 cm diameter spot 
with an energy density of 50 J/cm a at the surface of 
the irradiated artery. In the other three rats identical 
power and delivery times were used to give PDT 
intraluminally. An intraluminal fibre was made in the 
Department of Medical Physics (University College, 
London, U.K.) by removing the plastic from the distal 
lcm of a lmm diameter plastic clad fibre, and coating 
the tip with alternate layers of reflectance paint 
(Kodak) and lacquer. This was introduced into the 
common carotid artery via an arteriotomy in the 
external carotid artery and held in place by a 
ligature. 
(2) Dose response studies. Groups of ten rats were 
sensitised with A1SzPc (doses: 0.5, 1.0, 2.5 and 5 mg/ 
kg) and used for PDT of normal carotid arteries. PDT 
was given by external beam irradiation of 50 J/cm z at 
the surface of the irradiated artery. Following sensiti- 
sation the artery was exposed through a midline neck 
incision and the laser light given at the time of peak 
media A1SzPc fluorescence (30 min). A field, 1 cm in 
diameter, was irradiated and this was centred on the 
isolated left common carotid artery such that the 
cranial edge of the spot was I cm caudal to the origin 
of the external carotid artery. The remaining neck 
structures were excluded from the laser beam by 
placing a shield deep to the isolated artery and 
superficial to all other structures. Postoperatively the 
rats were maintained on standard rat chow, and water 
with a 12 h light/dark cycle. Groups of five rats 
(untreated, laser only and A1SzPc only) were used as 
controls. Five PDT treated rats at each A1SzPc dose 
were sacrificed at 3 days and five at fourteen days by 
a lethal dose of anaesthetic. A further 20 rats were 
sensitised with 2.5mg of A1S2Pc, treated with 50 J /cm 2 
of laser light and sacrificed at 1, 3 and 6 months. 
All irradiated arterial segments were fixed in 2% 
paraformaldehyde and 1% gluteraldehyde and 
embedded in paraffin. 10~m thick cross-sections were 
cut and stained with haematoxylin and eosin. Evalua- 
tion of cross-sections was by assessing medial cell 
numbers in a high power field (HPF) using a high 
power light microscope (Olympus IMT-2). Six repre- 
sentative counts were taken from a section obtained 
from the middle of the treated segment of each artery 
and the medial smooth muscle cell counts per HPF 
expressed as medians and interquartile range (30 
counts, six counts in each of five rats at each dose). 
Photodynamic therapy of balloon injured arteries 
Fifty rats were sensitised with 2.5 mg/kg of A1S2Pc 
and 50 were sham sensitised with 0.4ml of phosphate 
buffered saline. In all rats the left carotid artery and its 
bifurcation was exposed and a 2FG Fogarty arterial 
embolectomy catheter was introduced via a transverse 
arteriotomy in the external carotid artery and passed 
into the thoracic aorta. The balloon was inflated with 
0.2ml of saline and withdrawn to the carotid bifurca- 
tion with a rotating motion to produce uniform 
endothelial denudation and medial stretching in the 
common carotid artery. After three passages the 
catheter was removed and the external carotid was 
ligated. This procedure was performed by one oper- 
ator who had undergone a period of appropriate 
training. Subsequently, 25 sensitised and 25 sham- 
sensitised rats had laser irradiation of the common 
carotid artery. These balloon injured arteries were 
treated with 50 J/cm z of laser light, 30 min after 
A1SzPc injection. This gave the following groups of 25 
rats: (1) balloon onl)9 (2) balloon and sensitiser, (3) 
balloon and laser and (4) balloon, laser and sensitiser 
(PDT). 
Two, 4, 6, 12, and 26 weeks after injury and PDT, the 
rats were perfusion fixed in vivo using intra-aortic 
infusion of 2% paraformaldehyde and 1% gluter- 
aldehyde at 110-120mm Hg for 10 min immediately 
prior to killing the animal. The fixed segments of left 
common carotid artery were excised and placed in 
fresh fixative for 16 h. The treated segments of artery 
were carefully separated from the untreated segments 
and three separate cross-sections taken from the mid 
portion of each treated segment. Paraffin sections of 
the treated arteries were mounted on a glass slide, 
stained with haematoxylin and eosin and examined 
under a light microscope. Planimetric measurements 
were made directly from the slide in a blinded manner 
using an interactive computerised image analysis 
system (Colourmorph®, Perceptive Instruments, 
Essex U.K.). The ratio of the area of intimal hyper- 
plasia (FCIH) to the total area enclosed by the internal 
elastic lamina (IEL = intima + media) was calculated 
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Fig. 1. Diagram illustrating the ratio used to measure intimal 
hyperplasia. Lumen: area of radius "r" (bounded by intimal 
hyperplasia), IEL: area of radius of "rl" (bounded by internal elastic 
lamina) and FCIH (area of intimal hyperplasia) = IEL-lumen. 
FCIH/IEL represents the proportion of the luminal area occupied 
by intima hyperplasia. 
Photodynamic therapy in the normal artery 
Arteries treated by extraluminal nd intraluminal PDT 
and killed at 3 days showed identical histological 
changes. In both groups PDT produced complete 
depletion of cells in the treated artery leaving an 
artery consisting of an acellular connective tissue 
tube. 
The effectiveness ofA1S2Pc for PDT was assessed by 
its cytotoxicity on the medial smooth muscle cells in 
normal arteries after light exposure (Fig. 4 and Table 
1). PDT using 2.5 and 5.0 mg/kg  doses of A1S2Pc 
produced a complete depletion of cells in the treated 
artery to leave an artery consisting of an acellular wall. 
Doses of 0.5 and 1.0 mg/kg  of A1S2Pc produced a 
partial depletion of cells such that cell depletion was 
more pronounced in the area of the circumference 
closest o the source of the laser beam, creating a "half 
moon" effect on cellular depletion. The effect of the 1.0 
mg/kg  dose was greater than the 0.5 mg/kg  dose. 
(FCIH/IEL) and expressed as a percent which repre- 
sented the portion of the lumen occupied by the 
hyperplastic change (Fig. 1). 15 
Three sections were analysed from each rat (15 
sections per treatment group). Descriptive statistics 
were medians and range and statistical analysis of 
groups was by the Mann-Whitney Test. All animal 
care was in accordance with the Animal (Scientific 
Procedures) Act 1986 and Guidance on the operation 
of the Animal (Scientific Procedures) Act 1986 (HMSO 
publications U.K. 1990: HC 182. 
(a) 
Results 
Photosensitiser distribution in normal rat arteries 
Following intravenous injection the fluorescence 
intensity induced by A1S2Pc rises in areas correspond- 
ing to the three layers of the arterial wall as judged 
from the H&E slides (Fig. 2). The fluorescence inten- 
sities were highest within the arterial media with 
lower intensities in the intima and adventitia (Fig. 3). 
The time of peak fluorescence was 30 rain for all four 
doses of A1S~Pc, and in each layer of the artery. After 
peaking the fluorescence l vels dropped rapidly until 
6 h. Low but detectable vels of fluorescence were still 
present at 24 h. The magnitude of the fluorescence 
peaks was dose dependent, with the 5 mg/kg  dose 
producing the highest intensity (Fig. 3). 
(b) 
Fig. 2. (a) A1S2Pc fluorescence image (with intensity scale) in the rat 
carotid artery, and (b) corresponding haematoxylin and eosin 
stained section, 1 h after tail vein injection sensitisation. There is 
high uptake of sensitiser s the media ( rrow) of the arterial wall. 
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Arteries that were irradiated but not sensitised also 
produced a lesser degree of cell depletion (Fig. 5a-c). 
Following PDT, arteries howed loss of the endothelial 
layer. Arteries treated with A1S2Pc alone produced no 
change in the medial SMC counts or endothelial cell 
loss and were similar to arteries which had undergone 
no treatment at all. 
After 14 days the arteries howed a pattern of cell 
distribution in the media that was similar to that 
found at three days. These arteries differed, however, 
in that there was regeneration f cells in the endothe- 
lial layer which were confirmed as endothelial cells by 
specific staining with isolectin B4, (Vector Laboratories 
Ltd, Peterborough U.K.) which is specific for rat 
endothelium (Fig. 5d). 
Arteries treated with PDT (2.5 mg/kg A1S2Pc) were 
lined by endothelium but retained an acellular media 
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Fig. 3. (a) Graph showing the temporal profile of the fluorescence 
intensity (FI) expressed as counts per pixel (CPP) in the layers of rat 
carotid artery produced by 2.5 mg/kg  A1S2Pc. Note the high media 
levels, and the peak, 30 rain after injection in all three layers. (b) 
Temporal profile of the fluorescence in the arterial media for four 
doses of A1S2Pc. This shows the magnitude of the fluorescence 
intensity to increase with increasing A1SzPc dose. Results are 
expressed as mean and S.D. 
Table 1. Effects of PDT on arterial walls 
A1S2Pc Artery Treatment Endothelial Medial Intimal 
/mgkg -~ Interval (days) Ceils Cells Hyperplasia 
0.0" normal 0 + +++ - 
0.5 and normal 3 - + - 
1.0 normal 14 + - - 
2.5 and normal 3 - - - 
5.0 normal 14 + - - 
2.5 normal 28, 84, 172 + - +/ -  
0.0" ballooned 14 + +++ +++ 
2.5 ballooned 14 & 28 + - - 
2.5 ballooned 42, 84, 172 + - + 
Table showing the effects of sensitiser dosage on untreated and 
treated (PDT) carotid artery wall at varying intervals after treatment. 
(+) present and (-) absent findings at histology. *No PDT treatment. 
at 4, 6, 12, and 26 weeks, with an occasional vessel 
showing the presence of one or two medial cells only. 
All vessels were patent at the time of harvest and no 
haemorrhage, thrombosis or aneurysm formation was 
seen, but in I of 5 rats at 3 months and 2 of 5 rats at 6 
months mall areas of intimal hyperplasia were seen 
in the vessel umen (Fig. 5e). 
Results of photodynamic therapy of balloon injured 
arteries 
Arteries treated with PDT at the time of balloon 
angioplasty and harvested at 2 and 4 weeks were free 
of FCIH formation in all cases and consisted of an 
30 
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Fig. 4. Graph showing the cell count per high power field (HPF) at 
3 and 14 days after PDT treatment of normal arteries with 0.5, 1.0, 
2.5 and 5 mg/kg  of A1S2Pc sensitisation. Controls of laser only 
(0mg/kg), and N, normal untreated vessels are also shown. 
Treatment with A1SzPc (5mg/kg) only is not shown on the graph 
because the results did not differ from the untreated group. Results 
are expressed as medians and interuartile range. 
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endothelium lined connective tissue tube (on immu- 
nostaining) (Table 1). Although PDT inhibition of 
FCIH was complete at these early times the effect was 
only partial at 6, 12, and 26 weeks, and were 9%, 35% 
and 51% respectively, compared to untreated arteries. 
The amount of FCIH present increased with time in a 
non-linear manner. Arteries treated with laser alone 
(and to a lesser extent sensitiser alone) showed some 
reduction in the levels of FCIH when compared to 
untreated but balloon injured vessels (Fig. 6 a-c). 
Serial arterial sections showed the late presence of 
hyperplasia in effectively treated areas to be due to 
migration from areas of balloon injury which were 
peripheral to the irradiated field. At all times of the 
study the FCIH inhibition produced by PDT was 
significantly greater than that produced in the control 
groups (Fig. 7). Arteries injured by balloon angio- 
plasty but not treated by either sensitiser or laser 
showed a marked FCIH at 2 weeks which declined to 
moderate levels over 26 weeks. 
(d) (e) 
(c) 
:~  • ~ ~ i~ i~ ,~ i ,~ : .  !i~.~  
. i  
Fig. 5. Haematoxylin and eosin light micrographs of (a) normal rat carotid artery and after treatment with PDT using 2.5 mg/kg 
sensitisation. Arteries of rats sacrificed at (b) 3 days and (c) 14 days, (d) 26 weeks after PDT are shown. Arteries which were harvested 14 
days after laser only treatment (e), are also shown. The micrographs show the (a) normal arterial media cellpopulation, (b) complete 
depletion of medial and endothelial cells, and (c) depletion of media cells with endothelial cell regeneration at th  l er times. Minor intimal 
lesions (d) seen in two treated rats at 6 months, and (e) partial depletion of media cells produced by las r only, is also shown. Straight arrow: 
endothelial ceils; closed curved arrow: medial cells; open urved arrow: cellular intimal lesion. 
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No rats died prematurely during the period of 
follow-up but a few rats did not recover from the 
initial anaesthetic during surgery and were excluded. 
All vessels were patent at the time of harvest and no 
thrombosis or aneurysm formation were seen in any 
treated arteries. 
Discussion 
The use of PDT in the treatment of arterial disease has 
been based on the demonstrated preferential uptake of 
sensitiser into actively proliferating FCIHJ 5'16'22 If 
such differential sensitisation is mandatory then the 
use of PDT in the clinical setting would be limited to 
treating patients at some interval after angioplasty 
(when proliferation is in progress), with the cost 
implications of such repeat procedures. In studying 
our hypothesis that destruction of medial SMC, the 
source of migrating and proliferating SMC, will reduce 
FCIH we investigated the sensitisation and photo- 
dynamic therapy of normal contractile SMC, prior to 
(a] (b) , (c) , 
(d) ' {f} 
Fig. 6. Haematoxylin and eosin light micrographs of a balloon injured artery: (a) at 2 weeks, and (b) 26 weeks. PDT treated arteries at (c) 
2 weeks, (d) 6 weeks, (e) 12 weeks, and (f) 26 weeks. The micrographs show marked fibrocellular intimal hyperplasia in untreated balloon 
injured arteries. Medial smooth muscle cell depletion with varying amounts of intimal cell proliferation can be seen in PDT treated arteries. 
Straight arrow: internal elastic lamina; open curved arrow: intimal ining. 
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Fig. 7. Graph showing the effects of PDT (2.5 mg/kg A1S2Pc ) on 
balloon injured arteries as the percentage ratio of FCIH/IEL 2 to 26 
weeks after treatment. Results are expressed as medians and 
interquartile range. FCIH: area of fibrocellular intimal hyperplasia; 
IEL: area enclosed by internal elastic lamina. 
assessing the effects of angioplasty immediately fol- 
lowed by adjunctive A1S2Pc sensitised PDT. 
Fluorescence studies showed that A1S2Pc preferen- 
tially accumulated in the media of the vessel wall 
(compared with the endothelium and adventitia). The 
unsensitised arteries showed weak autofluorescence, 
but this was much less than that produced by 0.5 mg/ 
kg A1S2Pc. At all four doses peak fluorescence was 
observed 30 min after sensitisation: this time was used 
for laser illumination in all the PDT experiments. 
These fluorescence studies showed that normal arter- 
ies could be effectively sensitised. 
PDT of normal arteries caused depletion of medial 
smooth muscle cells in a dose dependent manner. The 
experiment using intra and extra-luminal irradiation 
gave identical result of total SMC depletion, therefore 
we used the extraluminal method for subsequent 
experiments because of its relative ease of application. 
Under our experimental conditions the lowest dose of 
A1S2Pc which caused total media SMC destruction in 
the whole vessel circumference was 2.5 mg/kg, thus 
this dose was chosen for PDT of balloon injured 
vessels. The long term studies on normal arteries 
showed the safety of PDT treatment which did not 
induce degeneration or aneurysm formation in the 
artery. The re-endothelialization f arteries confirms 
the results of Lamuraglia et al. 17 who also reported a
graded transition from areas of normal cell population 
to complete cell depletion in the treated area. We did 
not find migration of myofibroblasts into the media at 
any time. 
Use of 50 J/cm 2 of 675nm laser light alone produced 
some cell depletion in arteries. These cells did not 
undergo thermal destruction as the laser was held a 
few centimetres from the vessel and the laser power 
used was well within non-thermal limits. We speculate 
that these vessel underwent a PDT effect probably 
mediated by naturally occurring sensitisers inter- 
mediates uch as those in the haem pathway. Lamur- 
aglia et al. 17 using the same wavelength of continuous 
wave (CW) laser light, found no cellular effects. The 
contrasting results suggest hat CW and 12KHz laser 
light produce different biological effects. 
Following balloon injury PDT prevented FCIH 
formation in all cases at 2 and 4 weeks. At later times 
some FCIH was present in sections, although at all 
times PDT inhibition of FCIH was significantly greater 
than that seen in any of the controls. 
The rationale for using PDT in FCIH control is that 
a local treatment is being used to target a local 
condition. The uptake of sensitisers uch as Photo- 
frin® into experimefital atheromatous lesions in 
hyperlipidaemic animals and in vitro human plaques 
is well documented, z3-29 Studies have explored the 
effectiveness of sensitiser localisation in aiding plaque 
detection, and as a guide to improve safety in ablative 
laser therapy. None of these techniques have become 
clinically established. The first reports of arterial PDT 
involved attempts at treating experimental theroma 
in swine and rabbits using DHE. These produced 
unconvincing results. 24'27 
In 1990 PDT-induced inhibition of cultured SMC 
proliferation (Photofrin@ and UV light: 30-1200mJ/ 
cm 2) was reported by Dartsch et al. 22, and PDT of 
experimental balloon injured arteries quickly fol- 
lowed. Eton et al. 15 showed that PDT using Photofrin® 
(5mg/kg) and extraluminal application of laser light 
(630nm at 7.6 J /cm 2) nine days after balloon injury of 
rabbit carotid arteries inhibited FCIH. Photofrin® is a 
difficult sensitiser for arterial PDT because it causes 
marked and prolonged skin hypersensitivity in sun- 
light. The requirement of the patient to stay out of 
direct sunlight for up to 6 weeks means that photofrin 
is unlikely to be the sensitiser of choice for trials of 
arterial PDT in restenosis. Ortu et aI. 16 using phthalo- 
cyanine sensitisation (chloroaluminium sulphonated 
phthalocyanine [CASPc]: 5mg/kg) with extraluminal 
laser light (675 nm at 100 J/cm 2) treated rat carotid 
arteries 2 and 7 days after balloon injury and showed 
complete inhibition of balloon catheter induced FCIH 
at 14 days. More recent work from this group 17 has 
shown PDT inhibition of FCIH up to 16 weeks after 
treatment. A1S2Pc and CASPc are sulphonated phtha- 
locyanine sensitisers which unlike the porphyrins, 
show reduced and shorter lasting skin hypersensitiv- 
ity in ambient light~9; In contrast to CASPc which is a 
mixture of mono, di, tri, and tetra sulphonated 
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compounds, A1S2Pc is a chemically purified sensitiser 
with the added advantage that it may be available for 
clinical studies within a year or two. 
Depletion of medial SMC by PDT may raise concern 
over the integrity of the residual endothelial lined 
connective tissue wall. Rather than arterial weaken- 
ing, PDT appears to strengthen the connective tissue, 
probably by increasing collagen synthesis in the early 
phase of injury (I. Nyamekye, unpublished observa- 
tions). Studies on the magnitude of intraluminal 
pressure required to burst PDT treated arteries and 
normal arteries show that treated vessels require a 
higher intraluminal pressure before bursting than do 
normal arteries (Grant and Bown observations to be 
published). PDT may increase cross linking of colla- 
gen fibres within the vessel wall. 3° Similar observa- 
tions of increased connective tissue strength ave been 
reported in other organs following PDT treatment. 31
The acellular arterial wall remaining after PDT can be 
viewed as a more substantial form of the adventitial 
remains after endarterectom~ where the structural 
integrity of the artery is well maintained. Our normal 
arteries howed an increase in diameter at 3 days, but 
there was no increase in diameter between 2 weeks 
and 6 months (data not shown). The PDT effect is long 
lasting and it appears that the mature wall does not 
need medial SMC to survive. 
These results show that it is not necessary to delay 
PDT after balloon injury in order to prevent FCIH 
because PDT induced SMC death can occur in the 
absence of cell proliferation. We cannot at present 
recommend PDT in the settings of an arteriotomy 
(bypass grafting or endarterectomy) as the effects of 
PDT-induced SMC depletion on arteriotomy healing 
was not specifically addressed in this paper. We 
envisage that PDT given for prophylaxis of FCIH in 
angioplasty patients will be by way of an intraluminal 
light source at the time and site of angioplasty. A
fibreoptic angioplasty balloon catheter developed for 
simultaneous balloon inflation and radial intra-arterial 
laser irradiation could serve this purpose. Such fibres 
are currently under development. Balloon inflation at 
the time of irradiation will eliminate any problems of 
light absorption by blood, which might otherwise 
interfere with light penetration to the artery wall. The 
results of our preliminary experiments uggest hat 
PDT could be a successful treatment strategy for 
angioplasty restenosis. 
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